Latest News for: ok 11
Edit
Amendment to Annual Report by Foreign Issuer (Form 20-F/A) (OKYO Pharma Ltd)
Public Technologies 12 Aug 2025
). This Amendment No ... The only changes made to the Original Form 20-F are to revise the Exhibit Table to include the Company's Clawback policy, which was erroneously omitted from the previous filing ... Attachments Original document Permalink. Disclaimer.
Edit
Mitch McConnell’s legacy comes under fire in Kentucky race to replace him in the Senate
Mount Pleasant Morning Sun 04 Aug 2025
By BRUCE SCHREINER, Associated Press. CALVERT CITY, Ky ... Mitch McConnell. That’s when things got feisty ... “What are you running on?”. Morris touted his hard line stance on immigration and defended Trump’s tariffs as a boon for American manufacturing ... Sen.
Edit
Tiny heads, big impact: What sperm morphology tells us about fertility
Interesting Engineering 31 Jul 2025
A 2025 study on medaka embryos has revealed something remarkable. the size of a sperm’s head alone can determine whether or not it can trigger egg development across species through a process called gynogenesis ... sperm head morphology ... .
Edit
Annual Report for Fiscal Year Ending March 31, 2025 (Form 20-F) (OKYO Pharma Ltd)
Public Technologies 18 Jul 2025
Edit
Baltimore Sun
17 Jul 2025
Former JD’s Smokehouse in Bel Air to become HQ for local electrical contractor
Baltimore Sun
17 Jul 2025
Edit
OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain (Form 6-K) (OKYO Pharma Ltd)
Public Technologies 17 Jul 2025
). OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain. London and New York, NY, July 17, 2025. OKYO Pharma Limited (NASDAQ ... About NCP ... About Urcosimod (Formerly called OK-101) ... -1-.
Edit
OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain (Form 6-K) (OKYO Pharma Ltd)
Public Technologies 16 Jul 2025
Edit
OKYO Pharma to Present at the Bio International Convention (Form 6-K) (OKYO Pharma Ltd)
Public Technologies 11 Jun 2025
London and New York, NY, June 11, 2025 ... About Urcosimod (formerly called OK-101) ... published this content on June 11, 2025, and is solely responsible for the information contained herein.
Edit
Supplemental Prospectus (Form 424B5) (OKYO Pharma Ltd)
Public Technologies 11 Jun 2025
The date of this prospectus supplement is June 11, 2025 ... DILUTION S-11 ... The text in this prospectus will cover earlier press releases that used the initial name of OK-101, along with the later press releases using the urcosimod name ... S-11 ... OK-101.
Edit
First Post-Maintenance Flight Should Be Treated With Caution and Respect
Flying 10 Jun 2025
If you ask a seasoned aviation mechanic what flight is the most risk-prone for an aircraft, you may be surprised to hear that it’s the first flight after significant maintenance, such as the annual inspection ... READ MORE ... Teachable moment ... ....
Edit
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit (Form 6-K) (OKYO Pharma Ltd)
Public Technologies 19 May 2025
). OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit. London and New York, NY, May 19, 2025 ... Dr ... About Urcosimod (formerly called OK-101) ... Distributed via Public Technologies (PUBT), unedited and unaltered, on May 19, 2025 at 11.08 UTC.
- 1